STUDIES ON NEUROKININ ANTAGONISTS .4. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL DIPEPTIDE SUBSTANCE-P ANTAGONISTS - N-2-[(4R)-4-HYDROXY-1-[(1-METHYL-1H-INDOL-3-YL)CARBONYL]-L-PROLYL]-N-METHYL-N-(PHENYLMETHYL)-3-(2-NAPHTHYL)-L-ALANINAMIDE AND ITS RELATED-COMPOUNDS

被引:19
作者
HAGIWARA, D
MIYAKE, H
IGARI, N
KARINO, M
MAEDA, Y
FUJII, T
MATSUO, M
机构
[1] FUJISAWA PHARMACEUT CO LTD,NEW DRUG RES LABS,DEPT CHEM,YODOGAWA KU,OSAKA 532,JAPAN
[2] FUJISAWA PHARMACEUT CO LTD,NEW DRUG RES LABS,DEPT PHARMACOL,YODOGAWA KU,OSAKA 532,JAPAN
关键词
D O I
10.1021/jm00039a022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As an extension of our studies on discovering a novel substance P (SP) antagonist, we modified the previously reported dipeptide, N-2-[N-2-(1H-indol-3-ylcarbonyl)-L-lysyl]-N-methyl-N-(phenylmethyl)-L-phenylalaninamide (2b). The lysine part in 2b was first optimized to a (2S,4R)hydroxyproline derivative (3h),which is 2-fold more potent than 2b in [H-3]SP binding assay using guinea pig lung membranes. Next we modified the 1H-indol-3-ylcarbonyl part in 3h. Introduction; of a methyl group at the indole nitrogen enhanced the oral activity, while retaining the binding activity. Finally, we modified the phenylalanine part to culminate in the most potent compound 7k (FK888), which is a potent SP antagonist with NK1 selectivity as well as oral activity.
引用
收藏
页码:2090 / 2099
页数:10
相关论文
共 51 条
[2]   THE SYNTHESIS AND MICROBIOLOGICAL PROPERTIES OF BETA-(2-BENZOTHIENYL)-ALPHA-AMINOPROPIONIC ACID [J].
AVAKIAN, S ;
MOSS, J ;
MARTIN, GJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1948, 70 (09) :3075-3076
[3]  
BARNES PJ, 1990, ARCH INT PHARMACOD T, V303, P67
[4]   MODULATION OF NEUROGENIC INFLAMMATION - NOVEL APPROACHES TO INFLAMMATORY DISEASE [J].
BARNES, PJ ;
BELVISI, MG ;
ROGERS, DF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (05) :185-189
[5]  
BARNES PJ, 1986, LANCET, V1, P242
[6]   SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF ARGININE-VASOPRESSIN ANALOGS WITH 4-HYDROXYPROLINE IN POSITION-7 [J].
BUKU, A ;
SCHWARTZ, IL ;
YAMIN, N ;
WYSSBROD, HR ;
GAZIS, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (08) :1509-1512
[7]   A POTENT AND SELECTIVE NONPEPTIDE ANTAGONIST OF THE NEUROKININ-A (NK2) RECEPTOR [J].
EMONDSALT, X ;
VILAIN, P ;
GOULAOUIC, P ;
PROIETTO, V ;
VANBROECK, D ;
ADVENIER, C ;
NALINE, E ;
NELIAT, G ;
LEFUR, G ;
BRELIERE, JC .
LIFE SCIENCES, 1992, 50 (15) :PL101-PL106
[8]   AN IMPROVED SYNTHESIS OF INDAZOLE-3-CARBOXYLIC ACID [J].
FERRARI, M ;
RIPA, A ;
RIPA, G ;
SISTI, M .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1989, 26 (02) :531-532
[9]   SPANTIDE-II, AN EFFECTIVE TACHYKININ ANTAGONIST HAVING HIGH POTENCY AND NEGLIGIBLE NEUROTOXICITY [J].
FOLKERS, K ;
FENG, DM ;
ASANO, N ;
HAKANSON, R ;
WEISENFELDHALLIN, Z ;
LEANDER, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4833-4835
[10]   DESIGN AND SYNTHESIS OF ANTAGONISTS OF SUBSTANCE-P [J].
FOLKERS, K ;
ROSELL, S ;
CHU, JY ;
LU, LA ;
TANG, PFL ;
LJUNGQVIST, A .
ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1986, 40 (04) :295-302